Abrdn PLC Moderna, Inc. Transaction History

Abrdn PLC

$53.3 Billion
Q3 2024

A detailed history of Abrdn PLC transactions in Moderna, Inc. stock. As of the latest transaction made, Abrdn PLC holds 246,552 shares of MRNA stock, worth $9.76 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

246,552

Previous 292,662 15.76%

Holding current value

$9.76 Million

Previous $34.8 Million 52.59%

% of portfolio

0.03%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$63.64 - $125.14 $2.93 Million - $5.77 Million	-46,110 Reduced 15.76%	246,552 $16.5 Million
Q2 2024 Aug 09, 2024	SELL	$101.21 - $166.61 $17.3 Million - $28.4 Million	-170,452 Reduced 36.81%	292,662 $34.8 Million
Q1 2024 May 08, 2024	SELL	$85.37 - $115.44 $1.75 Million - $2.36 Million	-20,460 Reduced 4.23%	463,114 $49.3 Million
Q4 2023 Jan 31, 2024	BUY	$69.51 - $104.43 $27.8 Million - $41.8 Million	399,843 Added 477.53%	483,574 $48.1 Million
Q3 2023 Nov 06, 2023	SELL	$96.41 - $126.61 $518,107 - $680,402	-5,374 Reduced 6.03%	83,731 $8.65 Million
Q2 2023 Jun 20, 2024	SELL	$118.5 - $160.53 $415,816 - $563,299	-3,509 Reduced 3.79%	89,105 $10.8 Million
Q2 2023 Aug 04, 2023	SELL	$118.5 - $160.53 $415,816 - $563,299	-3,509 Reduced 3.79%	89,105 $10.8 Million
Q1 2023 Jun 20, 2024	SELL	$135.66 - $197.02 $207,152 - $300,849	-1,527 Reduced 1.62%	92,614 $14.2 Million
Q1 2023 Apr 28, 2023	SELL	$135.66 - $197.02 $207,152 - $300,849	-1,527 Reduced 1.62%	92,614 $14.2 Million
Q4 2022 Jun 20, 2024	SELL	$118.38 - $210.04 $43.7 Million - $77.5 Million	-368,973 Reduced 79.67%	94,141 $16.9 Million
Q4 2022 Feb 09, 2023	BUY	$118.38 - $210.04 $954,261 - $1.69 Million	8,061 Added 9.36%	94,141 $16.9 Million
Q3 2022 Nov 10, 2022	SELL	$118.07 - $194.18 $1.81 Million - $2.97 Million	-15,293 Reduced 15.09%	86,080 $10.2 Million
Q2 2022 Aug 05, 2022	SELL	$117.13 - $176.59 $120,058 - $181,004	-1,025 Reduced 1.0%	101,373 $14.6 Million
Q1 2022 May 04, 2022	SELL	$126.46 - $235.05 $1.92 Million - $3.56 Million	-15,161 Reduced 12.9%	102,398 $17.9 Million
Q4 2021 Feb 08, 2022	SELL	$225.82 - $368.51 $1.14 Million - $1.86 Million	-5,048 Reduced 4.12%	117,559 $29.9 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $20.1 Million - $43.9 Million	90,699 Added 284.25%	122,607 $47.2 Million
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $9,613 - $17,388	74 Added 0.23%	31,908 $7.5 Million
Q1 2021 May 06, 2021	BUY	$109.18 - $185.98 $49,895 - $84,992	457 Added 1.46%	31,834 $4.17 Million
Q4 2020 Feb 10, 2021	BUY	$65.74 - $169.86 $187,687 - $484,950	2,855 Added 10.01%	31,377 $3.28 Million
Q3 2020 Oct 21, 2020	BUY	$54.34 - $94.85 $689,846 - $1.2 Million	12,695 Added 80.21%	28,522 $2.02 Million
Q2 2020 Aug 10, 2020	BUY	$29.67 - $80.0 $469,587 - $1.27 Million	15,827 New	15,827 $1.02 Million

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.5B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account